MY Stock MarketDetailed Quotes

ORGABIO (0252)

Watchlist
  • 0.290
  • 0.0000.00%
15min DelayTrading Apr 17 10:46 CST
71.88MMarket Cap10.00P/E (TTM)

0252 ORGABIO

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2025
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
Total revenue
60.36%40.73M
66.60%39.05M
49.79%111.05M
63.62%34.2M
24.85%28M
36.15%25.4M
92.93%23.44M
26.01%74.14M
58.08%20.9M
82.08%22.43M
Cost of revenue
59.43%33.97M
71.36%32.4M
54.60%93.17M
70.54%29.56M
31.08%23.67M
42.63%21.31M
90.41%18.91M
23.05%60.26M
54.20%17.34M
68.65%18.06M
Gross profit
65.18%6.76M
46.75%6.65M
28.89%17.88M
30.04%4.64M
-0.89%4.33M
10.12%4.09M
104.19%4.53M
40.71%13.87M
80.03%3.57M
171.37%4.37M
Operating expense
12.15%2.9M
38.41%2.75M
28.17%10.21M
22.09%2.59M
35.68%2.76M
28.48%2.59M
9.71%1.99M
-15.79%7.97M
27.71%2.12M
-6.32%2.03M
Selling and administrative expenses
14.35%2.89M
37.91%2.69M
27.74%10.15M
22.10%2.58M
38.28%2.8M
26.82%2.53M
7.73%1.95M
-15.88%7.95M
26.61%2.11M
-7.32%2.03M
-Selling and marketing expense
140.00%24K
-13.04%20K
213.05%64.2K
1,000.00%22K
350.00%9K
-16.67%10K
475.00%23K
157.49%20.51K
5,814.29%2K
-33.33%2K
-General and administrative expense
13.85%2.87M
38.52%2.67M
27.26%10.09M
21.17%2.56M
37.98%2.79M
27.08%2.52M
6.69%1.93M
-16.02%7.93M
26.49%2.11M
-7.28%2.03M
Other operating expenses
-89.09%6K
64.86%61K
217.64%57.38K
20.00%12K
-1,020.00%-46K
223.53%55K
3,600.00%37K
58.13%18.07K
252.09%10K
127.78%5K
Operating profit
156.10%3.86M
53.26%3.9M
29.86%7.67M
41.70%2.05M
-32.69%1.57M
-11.55%1.51M
525.06%2.54M
1,373.10%5.91M
351.68%1.45M
518.07%2.34M
Net non-operating interest income (expenses)
19.59%-119K
-25.68%-186K
-59.29%-434.85K
-53.33%-207K
-11.63%-144K
-7.25%-148K
4.52%-148K
54.06%-272.99K
5.09%-135K
9.15%-129K
Non-operating interest income
----
----
-25.17%212.48K
----
----
----
----
--283.94K
----
----
Non-operating interest expense
-19.59%119K
25.68%186K
16.23%647.33K
53.33%207K
11.63%144K
7.25%148K
-4.52%148K
-6.28%556.93K
-5.09%135K
-9.15%129K
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
1,020.00%46K
-223.53%-55K
-3,600.00%-37K
-58.13%-18.07K
-9.75%5.93K
-127.78%-5K
Less:Write off
----
----
----
----
-1,020.00%-46K
223.53%55K
3,600.00%37K
58.13%18.07K
9.75%-5.93K
127.78%5K
Other non-operating income (expenses)
-67.40%162K
98.38%-11K
-6,110.90%-638.48K
-290.91%-210K
-120.25%-32K
204.91%497K
-467.50%-681K
-96.91%10.62K
-77.51%110K
222.45%158K
Income before tax
110.29%3.91M
115.86%3.7M
16.89%6.6M
14.85%1.63M
-40.96%1.4M
7.34%1.86M
1,199.24%1.72M
3,637.93%5.65M
113.02%1.42M
462.88%2.37M
Income tax
85.11%1.09M
50.54%971K
73.85%2.67M
154.14%1.14M
22.76%302K
-22.13%591K
650.00%645K
48.83%1.54M
1,129.31%447K
161.70%246K
Net income
122.04%2.81M
155.23%2.73M
-4.43%3.93M
-49.08%496K
-48.35%1.1M
30.38%1.27M
2,226.09%1.07M
565.71%4.11M
54.43%974K
384.18%2.12M
Net income continuous operations
122.04%2.81M
155.23%2.73M
-4.43%3.93M
-49.08%496K
-48.35%1.1M
30.38%1.27M
2,226.09%1.07M
565.71%4.11M
54.43%974K
384.18%2.12M
Noncontrolling interests
Net income attributable to the company
122.04%2.81M
155.23%2.73M
-4.43%3.93M
-49.08%496K
-48.35%1.1M
30.38%1.27M
2,226.09%1.07M
565.71%4.11M
54.43%974K
384.18%2.12M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
122.04%2.81M
155.23%2.73M
-4.43%3.93M
-49.08%496K
-48.35%1.1M
30.38%1.27M
2,226.09%1.07M
565.71%4.11M
54.43%974K
384.18%2.12M
Gross dividend payment
Basic earnings per share
121.57%0.0113
155.81%0.011
-4.82%0.0158
-48.72%0.002
-48.24%0.0044
30.77%0.0051
2,050.00%0.0043
561.11%0.0166
50.00%0.0039
383.33%0.0085
Diluted earnings per share
121.57%0.0113
155.81%0.011
-4.82%0.0158
-48.72%0.002
-48.24%0.0044
30.77%0.0051
2,050.00%0.0043
561.11%0.0166
50.00%0.0039
383.33%0.0085
Dividend per share
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q2)Dec 31, 2025(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024
Total revenue 60.36%40.73M66.60%39.05M49.79%111.05M63.62%34.2M24.85%28M36.15%25.4M92.93%23.44M26.01%74.14M58.08%20.9M82.08%22.43M
Cost of revenue 59.43%33.97M71.36%32.4M54.60%93.17M70.54%29.56M31.08%23.67M42.63%21.31M90.41%18.91M23.05%60.26M54.20%17.34M68.65%18.06M
Gross profit 65.18%6.76M46.75%6.65M28.89%17.88M30.04%4.64M-0.89%4.33M10.12%4.09M104.19%4.53M40.71%13.87M80.03%3.57M171.37%4.37M
Operating expense 12.15%2.9M38.41%2.75M28.17%10.21M22.09%2.59M35.68%2.76M28.48%2.59M9.71%1.99M-15.79%7.97M27.71%2.12M-6.32%2.03M
Selling and administrative expenses 14.35%2.89M37.91%2.69M27.74%10.15M22.10%2.58M38.28%2.8M26.82%2.53M7.73%1.95M-15.88%7.95M26.61%2.11M-7.32%2.03M
-Selling and marketing expense 140.00%24K-13.04%20K213.05%64.2K1,000.00%22K350.00%9K-16.67%10K475.00%23K157.49%20.51K5,814.29%2K-33.33%2K
-General and administrative expense 13.85%2.87M38.52%2.67M27.26%10.09M21.17%2.56M37.98%2.79M27.08%2.52M6.69%1.93M-16.02%7.93M26.49%2.11M-7.28%2.03M
Other operating expenses -89.09%6K64.86%61K217.64%57.38K20.00%12K-1,020.00%-46K223.53%55K3,600.00%37K58.13%18.07K252.09%10K127.78%5K
Operating profit 156.10%3.86M53.26%3.9M29.86%7.67M41.70%2.05M-32.69%1.57M-11.55%1.51M525.06%2.54M1,373.10%5.91M351.68%1.45M518.07%2.34M
Net non-operating interest income (expenses) 19.59%-119K-25.68%-186K-59.29%-434.85K-53.33%-207K-11.63%-144K-7.25%-148K4.52%-148K54.06%-272.99K5.09%-135K9.15%-129K
Non-operating interest income ---------25.17%212.48K------------------283.94K--------
Non-operating interest expense -19.59%119K25.68%186K16.23%647.33K53.33%207K11.63%144K7.25%148K-4.52%148K-6.28%556.93K-5.09%135K-9.15%129K
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges) 1,020.00%46K-223.53%-55K-3,600.00%-37K-58.13%-18.07K-9.75%5.93K-127.78%-5K
Less:Write off -----------------1,020.00%-46K223.53%55K3,600.00%37K58.13%18.07K9.75%-5.93K127.78%5K
Other non-operating income (expenses) -67.40%162K98.38%-11K-6,110.90%-638.48K-290.91%-210K-120.25%-32K204.91%497K-467.50%-681K-96.91%10.62K-77.51%110K222.45%158K
Income before tax 110.29%3.91M115.86%3.7M16.89%6.6M14.85%1.63M-40.96%1.4M7.34%1.86M1,199.24%1.72M3,637.93%5.65M113.02%1.42M462.88%2.37M
Income tax 85.11%1.09M50.54%971K73.85%2.67M154.14%1.14M22.76%302K-22.13%591K650.00%645K48.83%1.54M1,129.31%447K161.70%246K
Net income 122.04%2.81M155.23%2.73M-4.43%3.93M-49.08%496K-48.35%1.1M30.38%1.27M2,226.09%1.07M565.71%4.11M54.43%974K384.18%2.12M
Net income continuous operations 122.04%2.81M155.23%2.73M-4.43%3.93M-49.08%496K-48.35%1.1M30.38%1.27M2,226.09%1.07M565.71%4.11M54.43%974K384.18%2.12M
Noncontrolling interests
Net income attributable to the company 122.04%2.81M155.23%2.73M-4.43%3.93M-49.08%496K-48.35%1.1M30.38%1.27M2,226.09%1.07M565.71%4.11M54.43%974K384.18%2.12M
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 122.04%2.81M155.23%2.73M-4.43%3.93M-49.08%496K-48.35%1.1M30.38%1.27M2,226.09%1.07M565.71%4.11M54.43%974K384.18%2.12M
Gross dividend payment
Basic earnings per share 121.57%0.0113155.81%0.011-4.82%0.0158-48.72%0.002-48.24%0.004430.77%0.00512,050.00%0.0043561.11%0.016650.00%0.0039383.33%0.0085
Diluted earnings per share 121.57%0.0113155.81%0.011-4.82%0.0158-48.72%0.002-48.24%0.004430.77%0.00512,050.00%0.0043561.11%0.016650.00%0.0039383.33%0.0085
Dividend per share
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More